Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

An open-label, Phase I/II clinical trial of romaciclib (RVU120) as monotherapy and in combination with ruxolitinib in patients with intermediate or high-risk, primary or secondary myelofibrosis (POTAMI-61)

Tomasz Sacha, Marcin Rymko, Katarzyna Dulik, Sebastian Grosicki, Rostislav Kuklík, Adam Falkowski, Nemanja Nikic, Gary Wilkinson, Ewelina Kowalewska, Agnieszka Szymula, Milena Mazan, Agnieszka Sroka-Porada, Tomasz Rzymski, Hendrik Nogai, Marta Sobas, Tomasz Wrobel, Aneta Szudy-Szczyrek

Blood (2025) 146 (Supplement 1): 2045.

https://doi.org/10.1182/blood-2025-2045

Published: 2025

Journal Articles

An open-label, Phase 2 study of dapolsertib (MEN1703, SEL24) as monotherapy and in combination with glofitamab in patients with relapsed or refractory aggressive B-cell non-Hodgkin lymphoma

Blood (2025) 146 (Supplement 1): 5481.

https://doi.org/10.1182/blood-2025-5481

Published: 2025

Journal Articles

Trial in Progress: An Open-Label Clinical Trial of RVU120 As Monotherapy and in Combination with Ruxolitinib in Patients with Intermediate or High-Risk, Primary or Secondary Myelofibrosis (POTAMI-61)

Rostislav Kuklík, Adam Falkowski, Zachary Zaroogian, Milena Mazan, Agnieszka Szymula, Gary Wilkinson, Elżbieta Adamczyk, Jerzy Woźnicki, Marta Micek, Diego Coelho, Katarzyna Wiklik, Daniel Grzywczak, Hendrik Nogai, Tomasz Rzymski, Raajit Rampal

Blood (2024) 144 (Supplement 1): 6632.

https://doi.org/10.1182/blood-2024-204897

Published: 2024